Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: A population-based cross-sectional study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Hayford, Kyla T ^a   Shomik, Mohammed S ^b   Al Emran, Hassan M ^c   Moss, William J ^a   Bishai, David ^a   Levine, Orin S ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c DHAKA SHISHU HOSPITAL   (Bangladesh)

Author keywords

Bangladesh; Immune marker; Immunization; Maternal report; Measles; Oral fluid; Surveillance; Vaccination; Vaccination card

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; MEASLES VACCINE; VIRUS ANTIBODY;

ARTICLE; BANGLADESH; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH; HEALTH CARE SURVEY; HUMAN; IMMUNOLOGY; INFANT; MALE; MEASLES; MEASLES VIRUS; MEDICAL RECORD; REPRODUCIBILITY; SALIVA; STATISTICS; VACCINATION;

ANTIBODIES, VIRAL; BANGLADESH; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MEDICAL RECORDS; REPRODUCIBILITY OF RESULTS; RURAL HEALTH; SALIVA; VACCINATION;

EID: 84890537190     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-1211     Document Type: Article

References (46)

1. WHO, GIVS: global immunization vision and strategy 2006-2015 Geneva: WHO 2005
2. United Nations Development Programme: Millennium Development Goals (MDGs) http://www.undp.org/content/undp/en/home/mdgoverview/
3. Using immunization coverage rates for monitoring health sector performance: Measurement and interpretation issues. Bos E, Batson A, Health, Nutrition and Population (HNP) Discussion Papers Washington, DC, Bank W, 2000
4. Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Bolton P, Holt E, Ross A, Hughart N, Guyer B, Public Health Rep 1998 113 521 526 9847923 (Pubitemid 29001353)
5. Health cards, maternal reports and the measurement of immunization coverage: the example of Guatemala. Goldman N, Pebley AR, Soc Sci Med 1994 38 1075 1089 10.1016/0277-9536(94)90225-9 8042056 (Pubitemid 24096608)
6. Estimating vaccination coverage: Validity of household-retained vaccination cards and parental recall. Luman ET, Ryman TK, Sablan M, Vaccine 2009 27 2534 2539 10.1016/j.vaccine.2008.10.002 18948158
7. Immunization performance measurement in a changing immunization environment. Rodewald L, Maes E, Stevenson J, Lyons B, Stokley S, Szilagyi P, Pediatrics 1999 103 889 897 10103327 (Pubitemid 29275791)
8. Errors and correlates in parental recall of child immunizations: effects on vaccination coverage estimates. Suarez L, Simpson DM, Smith DR, Pediatrics 1997 99 3
9. Maternal recall error of child vaccination status in a developing nation. Valadez JJ, Weld LH, Am J Public Health 1992 82 120 122 10.2105/AJPH.82.1.120 1536315
10. Validity of reported vaccination coverage in 45 countries. Murray CJ, Shengelia B, Gupta N, Moussavi S, Tandon A, Thieren M, Lancet 2003 362 1022 1027 10.1016/S0140-6736(03)14411-X 14522532 (Pubitemid 37186879)
11. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lim SS, Stein DB, Charrow A, Murray CJ, Lancet 2008 372 2031 2046 10.1016/S0140-6736(08)61869-3 19070738
12. Estimating vaccination coverage: routine information or sample survey? Borgdorff MW, Walker GJ, J Trop Med Hyg 1988 91 35 42 3346934 (Pubitemid 19004427)
13. Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999. Zuber PL, Yameogo KR, Yameogo A, Otten MW Jr, J Infect Dis 2003 187 86 90 10.1086/368052 12721897 (Pubitemid 36583938)
14. Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons-Liberia, 2004. Huhn GD, Brown J, Perea W, Berthe A, Otero H, LiBeau G, Maksha N, Sankoh M, Montgomery S, Marfin A, et al. Vaccine 2006 24 730 737 10.1016/j.vaccine.2005. 08.077 16182416 (Pubitemid 43190079)
15. WHO, WHO Immunization Coverage Cluster Survey-Reference Manual Geneva, Switzerland: World Health Organization 2005
16. Brown J, Monasch R, Bicego G, Burton A, Boerma J, An assessment of the quality of national child immunization coverage estimates in population-based surveys USAID: Measure Evaluation 2002
17. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R, Wolfson L, Jones G, Birmingham M, Bull World Health Organ 2009 87 535 541 10.2471/BLT.08.053819 19649368
18. Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys. Tapia MD, Pasetti MF, Cuberos L, Sow SO, Doumbia MN, Bagayogo M, Kotloff KL, Levine MM, Pediatr Infect Dis J 2006 25 819 825 10.1097/01.inf. 0000232629.72160.bb 16940841 (Pubitemid 44325785)
19. Seroepidemiology of poliovirus antibody among the children in Eastern Turkey. Vancelik S, Guraksin A, Ayyildiz A, Beyhun NE, Indian J Med Res 2007 126 528 533 18219079 (Pubitemid 351663582)
20. Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models. Ohuma EO, Okiro EA, Bett A, Abwao J, Were S, Samuel D, Vyse A, Gay N, Brown DWG, Nokes DJ, Epidemiol Infect 2009 137 2 227 233 10.1017/ S0950268808000848 18544176
21. Evaluation of commercial assay detecting specific immunoglobulin g in oral fluid for determining measles immunity in vaccinees. Kremer JR, Muller CP, Clin Diagn Lab Immunol 2005 12 668 670 15879031 (Pubitemid 41184730)
22. Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Filmer D, Pritchett L, Demography 2001 38 115 132 11227840 (Pubitemid 33597463)
23. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Vyse AJ, Cohen BJ, Ramsay ME, Public Health 2001 115 201 207 10.1016/S0033-3506(01)00444-9 11429716 (Pubitemid 32529776)
24. Microimmune website http://www.microimmune.co.uk/new/measles-IgG-cap.htm
25. Siemens Enzygnost Anti-Measles Virus IgG Manual http://www.healthcare. siemens.com/infectious-disease-testing/systems/bep-iii-system/assays
26. National Institute of Population Research and Training (NIPORT) MaA, and ORC Macro, Bangladesh demographic and health survey 2004 Maryland, USA: Dhaka, Bangladesh and Calverton 2005
27. Measles-Rubella Surveillance and Outbreak Investigation http://www.searo.who.int/entity/immunization/documents/9789290223504/en/
28. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P, BMJ 2010 340 1626 10.1136/bmj.c1626 20483946
29. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG, Toureau S, Rohde J, Boulos C, N Engl J Med 1985 313 544 549 10.1056/NEJM198508293130904 4022091 (Pubitemid 15012833)
30. EPI, Bangladesh EPI coverage evaluation survey 2009 Dhaka, Bangladesh: Expanded Programme on Immunization 2009
31. Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. Hayford KT, Al-Emran HM, Moss WJ, Shomik M, Bishai D, Levine O, J Virol Methods 2013 193 512 518 10.1016/j.jviromet.2013.07.014 23872267
32. Gender inequity and age-appropriate immunization coverage in India from 1992 to 2006. Corsi DJ, Bassani DG, Kumar R, Awasthi S, Jotkar R, Kaur N, Jha P, BMC Int Health Hum Rights 2009 9 Suppl 1 3 10.1186/1472-698X-9-S1-S3 19828061
33. Immunization status of children admitted to a tertiary-care hospital of north India: reasons for partial immunization or non-immunization. Kumar D, Aggarwal A, Gomber S, J Health Popul Nutr 2010 28 300 304 20635642
34. Mothers' knowledge about vaccine preventable diseases and immunization coverage in a population with high rate of illiteracy. Rahman M, Islam MA, Mahalanabis D, J Trop Pediatr 1995 41 376 378 10.1093/tropej/41.6.376 8606451 (Pubitemid 26020174)
35. Measles susceptibility in children in Karachi Pakistan. Sheikh S, Ali A, Zaidi AK, Agha A, Khowaja A, Allana S, Qureshi S, Azam I, Vaccine 2011 29 3419 3423 10.1016/j.vaccine.2011.02.087 21396902
36. Choosing immunisation coverage indicators at the local level. Giorgi Rossi P, Faustini A, Spadea T, Perucci CA, Eur J Epidemiol 2004 19 979 985 10.1007/s10654-004-5758-6 15575358 (Pubitemid 39434556)
37. Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis. Lessler J, Metcalf CJ, Grais RF, Luquero FJ, Cummings DA, Grenfell BT, PLoS Med 2011 8 1001110 10.1371/journal.pmed.1001110 22039353
38. Accuracy of mothers' report regarding vaccination status of the children in urban Bangladesh. Selimuzzaman A, Ullah M, Haque M, J Teach Assoc RMC, Rajshahi 2008 21 40 43
39. Accuracy of routine data on MMR vaccination coverage and validity of parental recall of vaccination. Lyratzopoulos G, Aston R, Bailey K, Flitcroft J, Clarke H, Commun Dis Public Health 2002 5 305 310 12564246
40. Immunization in developing countries. Hadler S, Dietz V, Okwo-Bele JM, Cutts F, Vaccines Philadelphia: Saunder Elsevier, Plotkin SA, Orenstein WA, Offit PA, 5 2008 1541 1571
41. Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. Vainio K, Samdal HH, Anestad G, Wedege E, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge IS, Eur J Clin Microbiol Infect Dis 2008 27 461 465 10.1007/s10096-008-0460-3 18293018
42. Oral fluid, a substitute for serum to monitor measles IgG antibody? Goyal A, Shaikh NJ, Kinikar AA, Wairagkar NS, Indian J Med Microbiol 2009 27 351 353 10.4103/0255-0857.55457 19736406
43. Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). Nigatu W, Nokes DJ, Enquselassie F, Brown DW, Cohen BJ, Vyse AJ, Cutts FT, J Virol Methods 1999 83 135 144 10.1016/S0166-0934(99)00116-0 10598091 (Pubitemid 29528552)
44. The measles initiative: moving toward measles eradication. Christie AS, Gay A, J Infect Dis 2011 204 14 17 10.1093/infdis/jir075 21666155
45. Comparing measles with previous eradication programs: enabling and constraining factors. Keegan R, Dabbagh A, Strebel PM, Cochi SL, J Infect Dis 2011 204 54 61 10.1093/infdis/jir119 21666211
46. Impact of measles elimination activities on immunization services and health systems: findings from six countries. Hanvoravongchai P, Mounier-Jack S, Oliveira Cruz V, Balabanova D, Biellik R, Kitaw Y, Koehlmoos T, Loureiro S, Molla M, Nguyen H, et al. J Infect Dis 2011 204 82 89 10.1093/infdis/jir091 21666218